What’s the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.
Investors are always on the lookout for the next revolutionary technology or product. In recent times, this has…
UTSW Molecular Biologist Wins Prestigious Columbia Prize for Work on Duchenne Muscular Dystrophy » Dallas Innovates
Eric Olson, Ph.D. [Photo: UTSW] Eric Olson, Ph.D., founding chair of molecular biology at UT Southwestern Medical Center…